We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi Expands Into Cell Immunotherapies With Kiadis Purchase
Sanofi Expands Into Cell Immunotherapies With Kiadis Purchase
Sanofi announced that it is acquiring a portfolio of cell immunotherapies under development to treat various cancers through the purchase of Amsterdam-based biopharma Kiadis for $358 million.